Skip to main content

CORRECTION article

Front. Immunol., 08 August 2022
Sec. Mucosal Immunity
This article is part of the Research Topic The Human Lung Immuno-Inflammatory Network: Development, Acute and Chronic Disease, and Aging View all 11 articles

Corrigendum: Increased expression of LASI LncRNA regulates the cigarette smoke and COPD associated airway inflammation and mucous cell hyperplasia

  • 1Department of Immunology and Nano-Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, United States
  • 2Respiratory Immunology Program, Lovelace Respiratory Research Institute, Albuquerque, NM, United States
  • 3Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, United States
  • 4Department of Pharmacology, University of South Alabama, Mobile, AL, United States
  • 5Department of Environmental Medicine, University of Rochester Medical Center, Rochester, NY, United States

A corrigendum on
Increased expression of LASI LncRNA regulates the cigarette smoke and COPD associated airway inflammation and mucous cell hyperplasia

by Manevski M, Devadoss D, Long C, Singh SP, Nasser MW, Borchert GM, Nair MN, Rahman I, Sopori M, Chand HS (2022). . 2022 Jun 14; 13:803362. doi: 10.3389/fimmu.2022.803362

In the published article, there was an error in Table 1 as published. The information about the smoking history (Stop Smoking) for the subjects with ‘No COPD’ was duplicated. The corrected Table 1 and its caption appear below.

TABLE 1
www.frontiersin.org

Table 1 Demographics of the study cohort of COPD patients with clinically-defined GOLD stage severity and self-reported smoking history.

The authors state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: bronchial epithelial cells, cigarette smoke (CS), chronic obstructive pulmonary disease (COPD), long noncoding RNA (lncRNA), mucus hyperexpression, lncRNA antisense to ICAM-1 (LASI)

Citation: Manevski M, Devadoss D, Long C, Singh SP, Nasser MW, Borchert GM, Nair MN, Rahman I, Sopori M and Chand HS (2022) Corrigendum: Increased expression of LASI LncRNA regulates the cigarette smoke and COPD associated airway inflammation and mucous cell hyperplasia. Front. Immunol. 13:988069. doi: 10.3389/fimmu.2022.988069

Received: 06 July 2022; Accepted: 25 July 2022;
Published: 08 August 2022.

Edited and Reviewed by:

Nils Yngve Lycke, University of Gothenburg, Sweden

Copyright © 2022 Manevski, Devadoss, Long, Singh, Nasser, Borchert, Nair, Rahman, Sopori and Chand. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Hitendra S. Chand, hchand@fiu.edu

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.